Some experts think that the overly aggressive marketing of HPV vaccine Gardasil and the lobbying of Gardasil manufacturer Merck has led to the vaccine's potential over-prescription. According to the New York Times, "Some experts worry about the consequences of the rapid rollout of the new vaccines without more medical

A couple of major news outlets, including CBS and CNN have been reporting that several deaths and different major ailments have been "linked" to the Gardasil vaccine. One girl got pancreatitis, according to CNN, while CBS has reported on a girl with seizures and another who suffered from paralysis after getting

Gardasil has been denied delayed approval by the FDA for use in women ages 27-45. According to Reuters, "The U.S. Food and Drug Administration said in a letter regarding the application that it has completed its review and there are 'issues' that preclude approval within the expected review time frame." Merck was also

According to news reports, the FDA will decide whether or not to extend the the administration of Gardasil, the HPV vaccine, to women ages 27-45, by this summer. Currently, Gardasil is only approved for use in women ages 9-26. A spokeswoman for Merck, the company that produces Gardasil, emphasized that the vaccine

Since we already had our herpes news for today, here's your friendly HPV tidbit: many experts think that Gardasil, the only HPV vaccine currently on the market, is not permanently effective. Some researchers think that a booster may be needed after the ten-year mark. In addition, there is no proof that the vaccine

Herpes: It may actually not be so whatevs anymore. Researchers at the LSU School of Veterinary Medicine believe that the herpes virus could potentially help fight breast cancer. There's a big scientific explanation about why it's beneficial (something to do with cell replication and the immune system) that you can

Advertisement